ETERN Therapeutics
PrivateLast Round
Series B
Extension
Jun 26, 2026
Total Funding Raised
$13.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ETERN Therapeutics is a biotechnology company that develops novel small molecule drugs targeting undruggable proteins using a proprietary liquid-liquid phase separation (LLPS) technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ETERN Therapeutics Comparables
Compare ETERN Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nereid Therapeutics | 84% | |
| Transition Bio | 83% | |
| Dewpoint Therapeutics | 79% | |
ETERN Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jun 26, 2026 | ||||
| Series B Extension | Apr 1, 2024 | ||||
| Series B | Sep 1, 2021 | ||||
| Series A | Apr 9, 2020 | ||||
| Angel | Dec 31, 2018 | ||||
Angel | Dec 1, 2018 |
ETERN Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hillhouse Investment | Series B |
| TF Capital | Series B, Series A |
| Morningside Ventures | Series B |
| Wuxi High-tech Zone Venture Capital Holding Group | Series B Extension |
| BOHE Angel Fund | Series A |
| Wuxi Capital Group Co.,Ltd | Series B Extension |
| Apricot Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 91% MoM, reaching 4.6K.
- Jun 26, 2026
Led by AstraZeneca-CICC Healthcare Industrial Fund and Wuxi Capital Group.
ETERN Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ETERN Therapeutics's valuation, stock price, and market status.